Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04861285
Other study ID # RETRACT
Secondary ID 2021-A00179-32
Status Completed
Phase N/A
First received
Last updated
Start date May 10, 2021
Est. completion date November 12, 2021

Study information

Verified date June 2021
Source Septodont
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study design is a prospective, multi-center randomized, controlled, open label, 3-arm parallel group, post market clinical follow-up (PMCF) Clinical Trial. The aim of the study is to collect clinical performance and safety data from RACEGEL and RACESTYPTINE Solution. Three gingival retraction techniques are being studied: RACESTYPTINE Solution with cord, RACEGEL with cord and RACEGEL without cord. The study will demonstrate the expected performance of these 3 techniques in terms of sulcus opening, i.e. a lateral gingival displacement of at least 200 µm (state of the art) allowing the realization of pre-prosthetic impression with subgingivally margins. 90 subjects (teeth) requiring a dental restoration with subgingival margins for placement of a fixed prosthesis will be enrolled in 3 groups (30 in each group). For each participant, two dental impressions are performed: one impression before the gingival retraction and one impression immediately after the gingival retraction. Both impressions are scanned with 3D dental scanner and images are superimposed before analysis of tissue displacement.


Recruitment information / eligibility

Status Completed
Enrollment 88
Est. completion date November 12, 2021
Est. primary completion date November 5, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult male or female (age =18 years), - Patient requiring a dental restoration with subgingival margins on one or more teeth with placement of a single or multiple fixed prosthesis. Partially edentulous patients can be enrolled. - Good oral hygiene - Healthy periodontium and gingiva: probing depth =3 mm, no evidence of gingival inflammation (gingival index = 1), attachment loss (attached gingival >2 mm), bleeding on probing, or plaque accumulation (plaque index < 3) - Patient who received information and gave written consent. - Patient affiliated with a social security/protection plan. Exclusion Criteria: - Contraindication to taking impression evidenced at the latest on the day of inclusion visit (gingival index =2, sign of attachment loss or tooth mobility, probing depth >3 mm). - Known allergy to aluminum, aluminum salts or to one of the compounds of the formula of the gingival retraction material, or to one of the compounds of the impression material. - Patient with an unbalanced systemic disease (diabetes, thyroid disorders, history of oropharyngeal cancer), - Simultaneous participation in another interventional clinical investigation or trial, - Vulnerable Subjects

Study Design


Related Conditions & MeSH terms


Intervention

Device:
RACESTYPTINE Solution with cord
The dentist inserts a non-medicated gingival retraction cord into the sulcus and then impregnates the cord in situ with a few drops of RACESTYPTINE Solution. The impregnated cord is left in place a few minutes and then removed. The gingival sulcus is washed and gently air-dried before taking impression.
RACEGEL with cord
The dentist applies a sufficient amount of RACEGEL directly into the sulcus, following the contour of the prepared tooth, and then inserts a non-medicated gingival retraction cord into the sulcus. The impregnated cord is left in place a few minutes and then removed. The sulcus is washed and gently air-dried before taking impression.
RACEGEL without cord
The dentist applies a sufficient amount of RACEGEL directly into the sulcus, following the contour of the prepared tooth. The gel is left in place a few minutes and then removed. The sulcus is washed and gently air-dried before taking impression.

Locations

Country Name City State
France Cabinet dentaire Cesson-Sévigné
France Cabinet dentaire Rennes
France Cabinet dentaire Dr Rubin Rennes
France Cabinet dentaire Magister Rennes
France Cabinet dentaire - Médipole 35 Tinteniac

Sponsors (3)

Lead Sponsor Collaborator
Septodont Rennes University Hospital, Slb Pharma

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quantitative assessment of the lateral gingival displacement Two dental impressions are performed per participant at the same visit : one impression before the gingival retraction and one impression immediately after the gingival retraction. Both impressions are scanned with 3D dental scanner and images are superimposed before analyses. The lateral gingival displacement corresponds to the difference between pre- and post-displacement sulcus width measured in the 2 superimposed images of the pre- and post-retraction scanned models. Day 0
Secondary Quantitative assessment of the vertical gingival displacement The vertical gingival displacement corresponds to the greatest vertical distance between the crest of the gingiva in the 2 superimposed images of the pre- and post-retraction scanned models. Day 0
Secondary Oozing control assessment The dentist visually assesses the presence or absence of crevicular fluid in the sulcus immediately after removing the retraction material. Day 0
Secondary Bleeding control assessment The dentist visually assesses the stop of gingival bleeding (if there was one prior to the gingival retraction step), immediately after removing the retraction material. Day 0
Secondary Gingival index The Gingival Index records gingival inflammation on the prepared tooth in 3 grades according the following criteria:
Grade 0 = Normal gingiva. Grade 1 = Mild inflammation - slight change in color, slight edema. No bleeding on probing.
Grade 2 = Moderate inflammation - redness, edema, glazing. Bleeding on probing. Grade 3 = Severe inflammation - marked redness and edema, ulceration. Tendency toward spontaneous bleeding.
Day 0 (before and after the gingival retraction), Day 14 (end of study visit)
Secondary Papilla Bleeding index The Papilla Bleeding Index assesses gingival inflammation in the interdental papillae by recording bleeding on probing in the interdental areas. A periodontal probe is passed along the gingival margin to provoke bleeding and clinical findings are recorded according the following criteria:
Grade 0 = No bleeding on probing. Grade 1 = isolated bleeding spots present. Grade 2 = blood forms a red line on gingival margin. Grade 3 = heavy profuse bleeding.
Day 0 (before and after the gingival retraction), Day 14 (end of study visit)
Secondary Probing depth The probing depth measures the distance (in mm) from the free end of the gingival margin to the bottom of the periodontal pocket with a calibrated periodontal probe. A healthy periodontium and gingiva has a probing depth =3 mm. A probing depth >3 mm is pathologic. Day 0 (before and after the gingival retraction), Day 14 (end of study visit)
Secondary Adverse events Adverse events clinically observed by the dentist during the gingival retraction and impression procedures (Day 0) and at the end of study visit (Day 14) will be used to assess the safety. Day 0, Day 14 (end of study visit)
See also
  Status Clinical Trial Phase
Completed NCT02716727 - Comparison of Two Gingival Displacement Procedures N/A